Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Activating Tgr5 may help treat hair loss and bone loss.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Hair follicles play a crucial role in regulating skin barrier function.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

Understanding hair follicle development helps create treatments for hair loss and improve hair health.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Ruxolitinib can cause a delayed skin reaction on the nose.

Natural extracts may promote hair growth with fewer side effects than conventional treatments.